Mazdutide, a dual agonist drug was found to target weight reduction and additionally to manage blood glucose levels in individuals with overweight and obesity. The key highlights of this study was published in the recent edition of Frontiers in Endocrinology. Amidst the anticipation surrounding the efficacy of Mazdutide, the concerns regarding the scarcity of comprehensive evidence […]
South Korea: P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) is not inferior to 12-month DAPT in patients with coronary artery disease undergoing PCI with the latest generation of drug-eluting stents, findings from SHARE Randomized Clinical Trial have shown. The findings were published online in JAMA Network Open on March 7, 2024. The randomized […]
USA: An article published in Kidney International reports a new guideline from Kidney Disease: Improving Global Outcomes (KDIGO) that provides updated recommendations on the management of antineutrophilic cytoplasmic antibody (ANCA)–-associated vasculitis (AAV). The updated guideline addresses key recent developments, the recent regulatory approval of the C5a receptor inhibitor avacopan as an add-on therapy to the […]
Researchers have found in a new randomized trial that rapid syndromic PCR tests could complement or replace culture-based diagnostic methods for pneumonia. Lower respiratory tract infections, including CAP (community-acquired pneumonia), cause hospital admissions and mortality. Molecular tests can potentially optimize treatment decisions and CAP management, but limited evidence exists to support their routine use. According […]
Hoshiarpur: The District Consumer Disputes Redressal Commission, Hoshiarpur, recently slapped Rs 2 lakh compensation on a private hospital and its Cardiologist for an unsuccessful Coronary Percutaneous Old Balloon Angioplasty procedure on a patient. Observing that the doctor had not been vigilant while performing the procedure, the Commission noted, “…we conclude/ deduce that the OP 1 and […]
United States: The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s experimental treatment for early Alzheimer’s disease and will hold a meeting of outside experts to discuss its safety and efficacy, the company said. The FDA’s decision came as a surprise to company officials and many Alzheimer’s experts, who had expected […]
New Delhi: The drug major Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the bioequivalence (BE) study of the fixed-dose combination (FDC) Dapagliflozin Propanediol Monohydrate plus Sacubitril plus Valsartan Sodium Salt Film Coated Tablets. This came after Synokem Pharmaceutical presented its […]
Maharashtra- 1,000 MBBS seats will be added to 10 new medical colleges in Maharashtra from the forthcoming academic year. Recently, the Maharashtra government has sanctioned 2,440 teaching posts and 2,040 non-teaching posts for 10 new medical colleges in the state. Additionally, the patient capacity of the state’s public hospitals will increase by 4,300 beds, which […]
Jaipur: Rajasthan Chief Minister Bhajanlal Sharma said his government is working to expand and strengthen health services in the state. The government will get the work of all approved government medical colleges completed on priority to ensure people can access quality facilities in their own districts, he said while addressing virtually a foundation stone laying […]
New Delhi: Apollo Hospitals Group, India’s largest integrated healthcare provider unveiled the ZAP-X Gyroscopic Radiosurgery Platform, a revolutionary advancement in brain tumor treatment, marking a significant milestone as the first in South Asia to introduce this ground-breaking technology. With ZAP-X , Apollo Hospitals continues its legacy of innovation and commitment to providing world-class healthcare solutions […]